Inventor
Laurent Guillou
Inventor
Montpellier, FR
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07BGeneral methods of organic chemistry14%
C07CAcyclic or carbocyclic compounds14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
B01LChemical or physical laboratory apparatus for general use7%
C12MApparatus for enzymology or microbiology7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
G06NComputing arrangements based on specific computational models7%
G06TImage data processing or generation, in general7%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data7%
Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to CT HOSPITALIER UNIVERSITAIRE MONTPELLIER (2)· patent assignee history
2018–2021Patents assigned to INST NAT SANTE RECH MED (2)· patent assignee history
2018–2021Patents assigned to UNIV DAUVERGNE (2)· patent assignee history
2018–2021Patents assigned to UNIV MONTPELLIER (2)· patent assignee history
2018–2021Based in Montpellier, FR· patent location history
2021Patents assigned to CYTOVALE INC (1)· patent assignee history
2021Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CT HOSPITALIER UNIVERSITAIRE MONTPELLIER | 2 | 2018–2021 |
| INST NAT SANTE RECH MED | 2 | 2018–2021 |
| UNIV DAUVERGNE | 2 | 2018–2021 |
| UNIV MONTPELLIER | 2 | 2018–2021 |
| CYTOVALE INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Montpellier, FR | 2 | 2018–2021 |
| San Francisco, California, US | 1 | 2021 |